Skip to main content

Insight into gastrointestinal heterotopic pancreas: imaging evaluation and differential diagnosis


Heterotopic pancreas (HP) is an uncommon congenital abnormality in the developmental process of the pancreas, with gastrointestinal heterotopic pancreas (GHP) being the most common HP. The clinical manifestations of GHP may have variable patterns of presentation, dictated by both the anatomic location and the functional ability of the lesion. The most common imaging modality in detecting GHP is computed tomography (CT), while gastrointestinal barium fluoroscopy, endoscopic ultrasonography, and magnetic resonance imaging (MRI) are also applied. The density and enhancement patterns of GHP are consistent with histological classifications. GHP with a predominantly acinar tissue component manifests homogeneous and marked enhancement on CT images, whereas a predominantly ductal GHP presents heterogeneous and mild enhancement. On MRI, the appearance and signal intensity of GHP were paralleled to the normal pancreas on all sequences and were characterized by T1-weighted high signal and early marked enhancement. This article provides a comprehensive review of the histopathology, clinical manifestations, imaging features of various modalities, and differential diagnosis of GHP. It is hoped that this review will improve clinicians’ knowledge of GHP and aid in accurate preoperative diagnosis, thereby reducing the misdiagnosis rate.

Key points

  • Gastrointestinal heterotopic pancreas is an uncommon congenital abnormality in the developmental process of the pancreas.

  • The clinical manifestations of gastrointestinal heterotopic pancreas may have variable presentations decided by both the anatomic location and the functional ability of the lesion.

  • Some distinct imaging features of various modalities may support the diagnosis of gastrointestinal heterotopic pancreas.

  • Gastrointestinal heterotopic pancreas and other gastrointestinal subepithelial tumors could be differentiated by non-invasive imaging.


Heterotopic pancreas (HP) is a kind of congenital abnormality occurring during the developmental process of the normal pancreas, also known as ectopic pancreas, aberrant or accessory pancreas, pancreatic choristoma, or adenomyoma [1,2,3,4]. The true prevalence of HP is difficult to assess because most patients have no clinically significant symptoms. HP is found intraoperatively in approximate 0.2% of unrelated upper abdominal surgeries and 0.9% of gastrostomies [5, 6]. Autopsy results reveal the incidence of HP to be 0.5–13.7% approximately. The disease is most often seen in males, and the incidence peaks in the 4th, 5th, and 6th decades of life [6, 7]. HP lesions can arise in tissues throughout the upper gastrointestinal tract system, with surgical and autopsy data reporting a frequency within the stomach of 25–52%, 27–36% in the duodenum, and 15–17% in the jejunum, respectively [8]. Less common sites of HP include the ileum, esophagus, and Meckel's diverticulum, but also occasionally in the mesentery, hepatobiliary system, spleen, mediastinum, lung, and umbilical foramen [5]. This leads to further complexity in accurate diagnosis and treatment of HP as it is commonly confused with other disease processes.

Gastrointestinal heterotopic pancreas (GHP) is essentially analogous to the normal pancreas in terms of gross and histological specimen. GHP can be classified as a subepithelial lesion, which is defined as a mass covered by normal mucosa [9]. GHP appears as a solid intramural mass with a micro-lobulated border that is not clearly demarcated from the surrounding tissues [10]. GHP is mostly solitary (80%), and its diameter is mostly less than 3 cm, but the size also varies from 0.2 cm to 5.0 cm (Fig. 1) [10, 11].

Fig. 1

ad Axial plain/arterial/venous phases CT images of a 33-year-old female showed a 2.3 × 1.7 cm, round, and micro-lobulated subepithelial lesion (white arrows), indicating an endoluminal growth pattern of a heterotopic pancreas in the gastric body (ac). d Coronal venous phase CT image

Clinical manifestations

Patients with GHP are often asymptomatic, but some patients may illicit significant clinical manifestations. Characterization of GHP symptomatic lesions is slightly difficult due to the relative infrequency of this diagnosis and the variability and non-specificity in presentation, often leading to misidentification and suboptimal management in many cases. GHP is susceptible to the same pathological conditions as the normal pancreas, so its complications are like those of the normal pancreas, such as pancreatitis, pancreatic pseudocysts, even malignancy. In severe cases, it may cause acute abdomen such as gastrointestinal hemorrhage (hematemesis or melena), or even intestinal obstruction and intussusception (Fig. 2). Some complications may be misdiagnosed as malignant neoplasm. Groove pancreatitis is considered as an associated disease related to GHP, with its most important etiology to be cystic degeneration and fibrosis of the heterotopic pancreatic tissue embedded in the pancreaticoduodenal groove (Fig. 3).

Fig. 2

a–d A 46-year-old female presented with abdominal pain and anorexia over the course of one year with a weight loss. Contrast-enhanced axial CT images presented a 5.8 × 4.9 cm, endoluminal, and ill-defined mass (black arrows) in the duodenum accompanied by subsequent gastric outlet obstruction with surrounding inflammation and duodenal intussusception, and the patient was noted to have mild elevation in her amylase and lipase. The patient was subsequently taken to the operating room for antrectomy and Billroth II reconstruction. Her pathology demonstrated a heterotopic pancreas in the duodenum

Fig. 3

Groove pancreatitis in a 44-year-old male. a–f Axial contrast-enhanced CT images showed a sheetlike hypoattenuating mass (black arrows) in the pancreaticoduodenal groove and separated from the pancreatic head and the duodenum, with thickening of adjacent medial wall of the duodenum. a–c The final pathology demonstrated a 2.7 cm sized heterotopic pancreas in the duodenum (white arrows)

Esophageal lesions often bring about progressive dysphagia or epigastric pain, occasionally leading to gastroesophageal reflux and hiccup, and rarely hematemesis [12]. Secondary inflammation of the submucosal gastric lesions may lead to non-atrophic gastritis, but mucosal ulcers are rarely formed [13, 14]. Pyloric lesions may cause gastrointestinal obstruction. Jejunal lesions may act as a leading point for intestinal obstruction. Hepatopancreatic ampullary lesions give rise to biliary obstruction [5]. GHP in the hepatobiliary system tract is rare and rarely symptomatic [15], but it occasionally causes bile duct dilatation, bile duct obstruction, gallbladder effusion, cholecystitis, and even gallbladder perforation, which may be related to its heterotopic location. And its complications are not significantly distinct from other hepatobiliary systematic lesions [16].

In addition to the anatomic location, histological location within the layers of the visceral wall may also influence symptomatic presentation. GHP most commonly occurs between the submucosa and lamina propria but can be found in all layers of the visceral wall [14]. Submucosal lesions may be more likely to cause ulceration in local gastritis or duodenitis, while transmural lesions involving all layers of the bowel wall can lead to chronic inflammation and ultimately stricture or perforation [17].

Although location can often explain symptomatic presentation, it does not fully explain why some lesions are symptomatic and others found in similar locations are not. The remaining factor can be explained by the function of the lesion and the ability to perform the normal exocrine and endocrine functions of the pancreas. A histopathological evaluation by Heinrich in 1909 showed differences in the composition of these lesions which were later revised by Fuentes in 1973 [18, 19]. These classification systems classify GHP lesions according to the presence of all cellular components of functional pancreas tissues (Type I in both categories) and the presence of ducts, acinar tissue, or islet cells (Fuentes classification types II, III, and IV, respectively) [18, 19]. The presence or absence of histological elements may affect the function of the lesion and result in its ability (or inability) to produce symptoms. It has been proposed that lesions with functional exocrine potential may produce local chemical irritation of surrounding tissues, while lesions without appropriate duct drainage may lead to pancreatitis and the formation of pseudocysts within the lesion [20, 21].

Imaging evaluation of various imaging modalities

Accurate identification of GHP during diagnostic tests is important in determining the appropriate management. Unfortunately, many patients are misdiagnosed at the time of surgery or are thought to have other pathological changes. This often influences surgical decisions making and can lead to a more extensive resection than would otherwise be required. This was evident in the study by Zhang et al., which reported that over 54% of patients with GHP were misdiagnosed preoperatively [22]. Many lesions were considered malignant and underwent extensive resections. An accurate diagnosis of GHP, regardless of manifesting symptoms, may alter management and influence surgical decision. If the presence of GHP appears likely, appropriate imaging and diagnostic studies must be carefully evaluated. Lesions of adequate size can be identified by non-invasive imaging examination. Gastric HP is most located in the greater curvature side of the gastric antrum, within 6 cm to the pylorus [14]. Duodenal lesions are often posited in the descending duodenum, and jejunal lesions are most near the Treitz ligament [23]. Esophageal lesions are mostly placed in the distal third part of the esophagus [12].

In the past, the common imaging modality for GHP was gastrointestinal barium fluoroscopy. With the development of imaging technology, endoscopic ultrasonography (EUS), contrast-enhanced computed tomography (CT), and magnetic resonance imaging (MRI) are increasingly used for the detection and follow-up of GHP. Currently, the most applied imaging modality for GHP description is contrast-enhanced CT.

Upper gastrointestinal barium fluoroscopy

On barium examination, GHP has a typical appearance of an intramural tumor with a broad base and a smooth surface [10, 24]. An ulcer-like barium spot in the center of the lesion, which may be the rudimentary ductal drainage system of GHP, known as “umbilication” or “central umbilical sign,” is the characteristic imaging feature to differentiate GHP from other intramural gastric submucosal tumors. In one study [24], one fifth of GHP were detected typical “central umbilical sign,” and a large barium umbilication that resembled an ulcer or an ulcerative tumor was rare (Fig. 4) [24].

Fig. 4

A 15-year-old female presented with abdominal pain and distension underwent various imaging examinations. a Single spot image of the upper gastrointestinal tract on a barium fluoroscopic study demonstrated an intraluminal filling defect within the duodenum with a central indentation (white arrow) consistent with heterotopic pancreas. b Endoscopy showed a subepithelial lesion (white arrow) along the first portion of the duodenum with surrounding duodenitis. c–d Contrast-enhanced axial CT images revealed a hyper-enhanced lesion (white arrows) with ill-defined margin and thickening of the surrounding duodenal wall. e–h Non-contrast axial T2-weighted (e), pre-contrast T1-weighted (f), post-contrast arterial T1-weighted (g), and post-contrast venous T1-weighted images (h) showed a lesion within the first portion of the duodenum (white arrows) demonstrating T2-weighted slightly hyperintense signal, pre-contrast T1-weighted slightly hypointense signal, and post-contrast T1-weighted isointense like those of the normal pancreas

Endoscopic ultrasonography

Endoscopically, GHP shows as an endoluminal submucosal mass [6, 25]. Studies have shown that “central umbilical sign” is more easily detected in endoscopy than in conventional imaging [6]. Superficial endoscopic biopsies are often unable to diagnose GHP because of its subepithelial location and can also be difficult in the setting of ulceration, cystic degeneration, and in lesions that are located within the outer wall of the viscera [13, 26]. GHP most often presenting as a solid submucosal mass is hypoechoic relative to the mucosa and isoechoic relative to the mucosal muscle layer of gastrointestinal wall on EUS (Fig. 5). Further, EUS may help facilitate accurate targeting, delineate the contour and location of the lesion in the intestinal wall, and perform a fine-needle aspiration biopsy, which compensates for the deficiency of superficial endoscopic biopsy [5, 26,27,28,29].

Fig. 5

Images demonstrating the gastric body with a submucosa heterotopic pancreas (white arrows) identified within the wall of the stomach. a, b Contrast-enhanced axial CT images in arterial and venous phases. c, d Upper endoscopy images. e, f Endoscopic ultrasonography images

Contrast-enhanced computed tomography

GHP often presents as an intramural oval mass with indistinct margins on CT coronal images [23, 30]. GHP is usually small in diameter (often less than 3 cm) and tends to be an intraluminal growth pattern [6, 14, 31, 32]. The CT attenuation, enhancement heterogeneity, and enhancement degree of GHP correlate with its pathological histological compositions [5, 9, 10, 14, 23, 33]. It has been shown that the type with similar or stronger enhancement than the normal pancreas is dominated by acinar tissues, whereas the less enhancement type than the normal pancreas is composed mostly of ductal structures and hyperplastic muscular layers. Similarly, homogeneous enhancement pattern has a microscopic mainly consist of acinar component, whereas heterogeneity enhancement pattern gives priority to ductal component [6, 10, 14, 23]. The lesion margin seen on CT images is indistinct and slightly micro-foliated, consistent with the histopathology in which the alveoli is composed of a lobular morphology [14, 28]. Moreover, “a duct-like structure” imaging feature of GHP can be found as a thin hypodense strip of shadow in all phases of contrast-enhanced CT images, which varied in size from about 1 to 5 mm in width and 5 to 10 mm in depth [34]. It can be observed microscopically that the duct-like tissue of GHP communicates with the gastrointestinal lumen, but this may be difficult to observe on axial CT images [14, 23]. Rather, a study indicated that coronal and sagittal observation based on three-dimensional reconstruction may improve the characteristic sign detection of “a duct-like structure” (Fig. 6) [31]. GHP in the jejunum shares many same imaging features as those in the stomach and duodenum, but there are a few disparities: (a) while “central umbilical sign” and hyperenhancement of underlying mucosa of adjacent gastrointestinal wall can occasionally be observed in the gastric and duodenal lesion, both are rare in the jejunal lesion [23], (b) GHP in the stomach or duodenum manifest endoluminal growth pattern predominantly, whereas no dominant growth pattern was found in jejunal lesion: endoluminal, exophytic, and mixed growth patterns were all distributed [23], (c) “a duct-like structure” sign in the jejunal lesion is relatively more difficult to identify than that in the gastric lesion [10, 23], and a study found that only three cases (3/16, 19%) of jejunal lesions were observed “a duct-like structure” signs on CT images [23]. Gastric HP is often endoluminal growing, mostly located in the antrum, with an oval or flat shape, and the ratio of long diameter (LD) to short diameter (SD) is likely greater than 1.3 or 1.4 (Fig. 7) [14, 32]. Gastric HP grows internally into the intestinal lumen without distorting its external contour, contrary to the pattern growing exophytic from the intestinal wall without bulging into the lumen. In contrast, there is also a proportion of round HP lesion in the duodenum or jejunum, which has been suggested to result from the tension difference existing between the intestinal wall and the gastric wall [6, 23].

Fig. 6

a, b Coronal and axial enhanced CT images of a heterotopic pancreas in the duodenum of a 53-year-old male showed a 1.3 cm × 0.9 cm, endoluminal lesion (white arrows) with a lobulated margin, presenting round contour on axial image while flat pattern on coronal CT image. Small duct-like structure (black arrow) was seen within the lesion, which measured with a long diameter to short diameter > 1.4 on coronal CT image. c, d Axial enhanced CT images of a heterotopic pancreas in the gastric antrum of a 58-year-old male showed a 1.2 cm × 0.8 cm, oval, ill-defined, and endoluminal lesion (white arrows), with a long diameter to short diameter > 1.4

Fig. 7

a–c Axial plain (a) /arterial (b) /venous (c) phases CT images of a heterotopic pancreas in the duodenum of a 57-year-old female showed a 1.2 cm, round, well-defined, and mixed-growing lesion (white arrows). Small duct-like structure (black arrows) was vaguely seen within the lesion in each phase, presenting slightly hypo density compared to the surroundings. d–f Axial arterial (d) /Venous (e) /coronal venous (f) phases CT images of a heterotopic pancreas in the duodenum of a 58-year-old male showed a 1.3 cm × 0.9 cm, flat lesion (white arrows) with a lobulated contour and an exophytic growth pattern. Small duct-like structure (black arrows) was seen within the lesion in each phase

Magnetic resonance imaging

The appearance and signal intensity of GHP resembles that of the normal pancreas in all MRI sequences [5, 35]. GHP shows characteristic discriminatory high signal on T1-weighted images [5]. GHP and the normal pancreas often appear similar signal intensity and paralleled enhancement degree in associated MRI sequences [35], with the lesion exhibiting marked enhancement in the late arterial phase. But some GHP may display more pronounced enhancement than the normal pancreas. Magnetic resonance cholangiopancreatography (MRCP) plays an important auxiliary role in identifying the rudimentary ductal system. The dilated duct of GHP, also known as the “heterotopic duct sign,” is more easily manifested on T2-weighted images and MRCP images, a specific sign that helps to distinguish GHP from other submucosal lesions (Fig. 8) [5, 36].

Fig. 8

a–h Non-contrast axial T1-weighted (a), pre-contrast axial T1-weighted (b), post-contrast axial T1-weighted (c, d), and post-contrast coronal T1-weighted (h) images showed a lesion within the duodenum (white arrows) demonstrating T1-weighted hyperintense or isointense signal like those of the normal pancreas. This tissue showed similar imaging characteristics of the normal pancreas on axial T2-weighted (e) and coronal true fast image with steady-state precession (True-FISP) (f) images (white arrows). Magnetic resonance cholangiopancreatography image (g) showed a nodular filling defect in the duodenum

Differential diagnostic performance between GHP and other gastrointestinal subepithelial tumors

GHP is still prone to misdiagnosis in clinical practice. Identifying the imaging features of GHP can help to distinguish it from tumors and thus avoid unnecessary surgery. The main differential diagnostic tumors of GHP are other gastrointestinal subepithelial tumors, including gastrointestinal stromal tumor (GIST), gastroduodenal glomus tumor (GGT), schwannomas, leiomyomas, and so on. The differential diagnosis of the complications of GHP pancreatitis includes groove pancreatitis, myoadenomatosis, pancreatic hamartoma of the duodenum, pancreatic adenocarcinoma involving the biliary tree, and so on [37,38,39]. The non-invasive imaging assessment literatures centered on contrast-enhanced CT, EUS, and MRI.

Contrast-enhanced computed tomography

Contrast-enhanced CT is the most applied imaging modality for differentiating GHP from other subepithelial tumors. Kim et al. [14] initially proposed a research using sensitivity, specificity, odds ratio, and combination of variables to investigate the role of contrast-enhanced CT for differentiating GHP from GIST and gastrointestinal leiomyoma with qualitative and quantitative imaging features. It firstly evinced a morphological growing method with a LD to SD ratio to assess GHP and other subepithelial tumors. When significant identifying features were used in combination, the values of sensitivity and specificity were improved somehow. Then, a similar study applied above features and methods to evaluate GGT from other subepithelial lesions including GHP and GIST [40]. Although it only focused on GGT, its quantitative parameters introduced an approach of quantification and precision of the lesion CT attenuation value: using the lesion to aorta ratio in each phase [40].

Nevertheless, previous studies didn’t make usage of receiver operating characteristic analysis to determine the diagnostic performance of contrast-enhanced CT. Later, studies filled the gap by addressing the shortcoming, though lack of pathologic to radiologic correlation [31, 32, 41]. Compared to Kim et al.’s study, Yang et al. [31] not only individualized CT attenuation by using the lesion to aorta ratio method, but also combined significant variables in univariate analysis and achieved higher area under the curve values. Liu et al. [41] and Li et al. [32] both focused on the differentiation of gastric HP from gastric stromal tumors (GST); they have some differences and emphases. Liu et al. [41] collected all GST in their study with a diameter limitation of ≥ 1 cm and calculated the CT attenuation disparities by using the enhanced CT attenuation value minus that of unenhanced phase while Li et al. [32] limited the lesion diameter of < 3 cm, utilized stratified random sampling method to rate same sample sizes of gastric HP and GST, and employed the group validation method to prove the drawn conclusion of the primary cohort. Further, the lesion-to-pancreas ratio in venous phase was operated. It manifested that significant variables in the primary cohort were also significant in the validation cohort, which emphasized and evidenced the authenticity and reliability of research results.

Endoscopic ultrasonography

At present, studies of EUS bring into play a role in describing and figuring the endosonographic features of GHP [28, 42]. Few studies have concentrated on distinguishing GHP from other subepithelial tumors. An endosonographic study evaluated the morphological and echoic features of gastric HP, GIST, and other mesenchymal tumors and came to significant conclusions [42]. Park et al. [28] compared the efficacy between CT combined EUS and CT only in differentiating endoscopically suspected gastroduodenal HP from GIST and other subepithelial lesions. With its five-point scale scoring evaluation system, they revealed that CT and EUS were both useful, and CT combined EUS signified a superior diagnostic accuracy than CT only significantly [28]. They pointed out that each imaging technique has its dominances and drawbacks, which might germinate conceptions on the combination of various imaging features of a single modality and combination of various imaging modalities in evaluation.

Magnetic resonance imaging

MRI has a superior ability in identifying GHP based on its multi-parameters imaging and multiple sequences, especially on MRCP and T2-weighted images. The only study assessed MRI with diffusion-weighted imaging findings of GHP and other gastrointestinal submucosal tumors, suggesting that qualitative and quantitative parameters could be helpful in differentiation diagnosis [43]. Preoperative MRI is supposed to be more widely applied in submucosal tumors for non-invasive detection and differentiation.

Main differentiation: features of other gastrointestinal subepithelial tumors

Gastrointestinal stromal tumor

GIST is the most common submucosal tumor that originates from interstitial Cajal cells in the muscular layer of the gastrointestinal wall and can occur anywhere along the digestive tract. The most common location of GST is the fundus or body [14]. Most of GIST show exophytic growth or mixed growth, with a mixed growth pattern including both endoluminal and exophytic parts: in a dumbbell shape, a growth pattern that is rare in GHP (Fig. 9) [23].

Fig. 9

a–c Heterotopic pancreas in a 61-year-old female. Axial contrast-enhanced CT images obtained during the plain (a) /arterial (b) /venous (c) phases showed a heterogeneous enhanced flat mass (white arrows) in the gastric antrum. The mass had an endoluminal growth pattern, which is more common with heterotopic pancreatic lesion in the stomach. d–f Gastrointestinal stromal tumor in a 41-year-old male. Axial contrast-enhanced CT images obtained during the plain (d) /arterial (e) /venous (f) phases also showed a homogeneous enhancing round mass (white arrows) in the gastric antrum with the same endoluminal growth pattern

The typical appearance of primary GIST is a submucosal mass with irregular contour and heterogeneous enhancement, which may be accompanied by mucosal ulceration, necrosis, cystic degeneration, hemorrhage, calcification, and presentation of enlarged draining vessels [44]. Nearly half of GIST patients are found with metastases, and the liver and peritoneum are organs most likely to be involved [45]. GIST smaller than 2 cm is often endoluminal growing with well-defined border, presenting homogeneous hypodense attenuation, so it might be challenged to distinguish small GIST from other gastrointestinal benign tumors [46, 47].

Gastrointestinal Schwannoma

Gastrointestinal schwannoma is thought to originate as an over proliferation of Schwann cells within the autonomic nervous system of the gastrointestinal tract and often manifests as a prominent lymphatic cuff-like mass [48]. Gastrointestinal schwannoma are relatively rare, accounted for 4% of all benign gastric tumors, with the most common site being the stomach, followed by the colon and the rectum [49]. Gastrointestinal schwannoma usually presented as a submucosal lesion with an endogenous or exogenous growth pattern, and its common CT presentation is homogeneous and moderate enhancement, which means calcification, cystic changes, hemorrhage, and necrosis are rarely observed in gastrointestinal schwannoma [50, 51].

Gastrointestinal leiomyoma

Gastrointestinal leiomyoma is benign, not requiring surgery unless obstruction or compression symptoms. The most common location of gastrointestinal leiomyoma is the gastroesophageal junction, while in the stomach it is usually located in the cardia [52]. Gastrointestinal leiomyoma often displays as a small homogeneous hypodense mass with mild to moderate enhancement, often with endoluminal growth pattern (Fig. 10) [53].

Fig. 10

a–c Heterotopic pancreas in a 48-year-old female. Axial contrast-enhanced CT images obtained during the plain (a) /arterial (b) /venous (c) phase showed a flat mass (white arrows) in the gastric cardia, with a tendency to grow horizontally. d–f Gastrointestinal leiomyoma in a 42-year-old male. Axial contrast-enhanced CT images also demonstrated a same flat mass (white arrows) in the gastric cardia, but with a vertical growth tendency compared to the horizontal axis. g–i Gastrointestinal leiomyoma in a 48-year-old female. Axial contrast-enhanced CT images also revealed a vertically growing and round mass (white arrows) in the gastric cardia

Gastrointestinal neuroendocrine tumors

Gastrointestinal neuroendocrine tumor is a rare and slow-growing tumor derived from intestinal villous-like cells [54]. More than two-thirds of small bowel neuroendocrine tumors occur in the terminal ileum within 60 cm of the ileocecal valve [55]. Neuroendocrine tumor of the duodenum or jejunum varies biologically and clinically [56]. Carcinoid syndrome generally occurs when jejunal neuroendocrine tumor metastasize to the liver [57]. Appendiceal neuroendocrine tumor is most often encountered after appendectomy [58]. Colonic neuroendocrine tumor is usually large at the time of diagnosis, i.e., tumor with local or distant metastases [59].

Characteristic CT signs help to distinguish GHP from other submucosal lesions in the gastrointestinal tract that are seem similar oval or flat in shape. GHP is mostly a small, solitary lesion located distal to the gastric antrum with a large LD/SD ratio, and its density and enhancement pattern resemble that of the normal pancreas. GIST is mostly a mixed-growing, abundant bloody supply mass in the submucosa of the gastrointestinal tract, commonly with mucosal ulceration and amorphous calcification. Gastrointestinal schwannoma generally shows as a round, homogeneous, hypodense lesion in the stomach. Gastrointestinal leiomyoma customarily presents as a small, hypodense, mild enhancement, and intraluminal-growing lesion in the esophagogastric junction. Neuroendocrine tumor of the gastrointestinal tract varies according to its classification and location and thus imaging performance. Familiarity with their respective imaging manifestations can assist clinicians in making a diagnosis before treatment.


GHP is a variant congenital of development, which is rarely detected on prospective imaging, while most cases are discovered at surgery or autopsy. Comprehension of the common sites of occurrence and imaging features of GHP is key aspects of accurate preoperative diagnosis. Clinician and radiologist should also be aware of the histoembryological and pathological features of GHP, mastering with clinical manifestations and related complications of GHP, and clear about the diagnostic points of differentiation between GHP and other gastrointestinal submucosal tumors, to avoid as much as possible underdiagnosis and misdiagnosis of such disease during work.

Availability of data and materials

The data and material are included in this manuscript.



Computed tomography


Endoscopic ultrasonography


Gastroduodenal glomus tumor


Gastrointestinal heterotopic pancreas


Gastrointestinal stromal tumor


Gastric stromal tumors


Heterotopic pancreas


Long diameter


Magnetic resonance cholangiopancreatography


Magnetic resonance imaging


Short diameter


  1. 1.

    Beltrán MA, Barría C, Naquira C, Almonacid J, Cruces KS (2007) Pancreatic choristoma in the gallbladder: report of two cases. Rev Med Chil 135(10):1318–1322

    Article  Google Scholar 

  2. 2.

    Matsushita M, Hajiro K, Okazaki K, Takakuwa H (1999) Gastric aberrant pancreas: EUS analysis in comparison with the histology. Gastrointest Endosc 49(4 Pt 1):493–497.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Matsushita M, Takakuwa H, Nishio A (2003) Endosonographic features of gastric adenomyoma, a type of ectopic pancreas. Endoscopy 35(7):621–622. (author reply 623)

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Pavlov PV, Kiryukhin AP, Tertychnyi AS, Kitsenko YE (2020) A rare case of aberrant pancreas in the colon: choristoma of Bauhin’s valve. Endoscopy 52(4):E120-e121.

    Article  PubMed  Google Scholar 

  5. 5.

    Kung JW, Brown A, Kruskal JB, Goldsmith JD, Pedrosa, I (2010) Heterotopic pancreas: typical and atypical imaging findings. Clin Radiol 65(5):403–407.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Wei R, Wang QB, Chen QH, Liu JS, Zhang B (2011) Upper gastrointestinal tract heterotopic pancreas: findings from CT and endoscopic imaging with histopathologic correlation. Clin Imaging 35(5):353–359.

    Article  PubMed  Google Scholar 

  7. 7.

    Sandrasegaran K, Maglinte DD, Cummings OW (2006) Heterotopic pancreas: presentation as jejunal tumor. AJR Am J Roentgenol 187(6):W607–W609.

    Article  PubMed  Google Scholar 

  8. 8.

    Dolan RV, Remine WH, Dockerty MB (1974) The fate of heterotopic pancreatic tissue. A study of 212 cases. Arch Surg 109(6):762–765.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Lee NK, Kim S, Kim GH et al (2010) Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics 30(7):1915–1934.

    Article  PubMed  Google Scholar 

  10. 10.

    Park SH, Han JK, Choi BI et al (2000) Heterotopic pancreas of the stomach: CT findings correlated with pathologic findings in six patients. Abdom Imaging 25(2):119–123.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Mortelé KJ, Rocha TC, Streeter JL, Taylor AJ (2006) Multimodality imaging of pancreatic and biliary congenital anomalies. Radiographics 26(3):715–731.

    Article  PubMed  Google Scholar 

  12. 12.

    Ulrych J, Fryba V, Skalova H, Krska Z, Krechler T, Zogala D (2015) Premalignant and malignant lesions of the heterotopic pancreas in the esophagus: a case report and review of the literature. J Gastrointestin Liver Dis 24(2):235–239.

    Article  PubMed  Google Scholar 

  13. 13.

    Lai EC, Tompkins RK (1986) Heterotopic pancreas. Review of a 26 year experience. Am J Surg 151(6):697–700.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Kim JY, Lee JM, Kim KW et al (2009) Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma. Radiology 252(1):92–100.

    Article  PubMed  Google Scholar 

  15. 15.

    Elpek GO, Bozova S, Küpesiz GY, Öğüş M (2007) An unusual cause of cholecystitis: heterotopic pancreatic tissue in the gallbladder. World J Gastroenterol 13(2):313–315.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Sumiyoshi T, Shima Y, Okabayashi T et al (2014) Heterotopic pancreas in the common bile duct, with a review of the literature. Intern Med 53(23):2679–2682.

    Article  PubMed  Google Scholar 

  17. 17.

    Gurocak B, Gokturk HS, Kayacetin S, Bakdik S (2009) A rare case of heterotopic pancreas in the stomach which caused closed perforation. Neth J Med 67(7):285–287

    CAS  PubMed  Google Scholar 

  18. 18.

    Trifan A, Târcoveanu E, Danciu M, Huţanaşu C, Cojocariu C, Stanciu C (2012) Gastric heterotopic pancreas: an unusual case and review of the literature. J Gastrointestin Liver Dis 21(2):209–212

    PubMed  Google Scholar 

  19. 19.

    Gaspar Fuentes A, Campos Tarrech JM, Fernández Burgui JL et al (1973) Pancreatic ectopias. Rev Esp Enferm Apar Dig 39(3):255–268

    CAS  PubMed  Google Scholar 

  20. 20.

    Bryan DS, Waxman I, Matthews JB (2014) Gastric obstruction due to intramural pseudocyst associated with heterotopic pancreas. J Gastrointest Surg 18(6):1225–1226.

    Article  PubMed  Google Scholar 

  21. 21.

    Ormarsson OT, Gudmundsdottir I, Mårvik R (2006) Diagnosis and treatment of gastric heterotopic pancreas. World J Surg 30(9):1682–1689.

    Article  PubMed  Google Scholar 

  22. 22.

    Zhang Y, Sun X, Gold JS et al (2016) Heterotopic pancreas: a clinicopathological study of 184 cases from a single high-volume medical center in China. Hum Pathol 55:135–142.

    Article  PubMed  Google Scholar 

  23. 23.

    Kim DW, Kim JH, Park SH et al (2015) Heterotopic pancreas of the jejunum: associations between CT and pathology features. Abdom Imaging 40(1):38–45.

    Article  PubMed  Google Scholar 

  24. 24.

    Kilman WJ, Berk RN (1977) The spectrum of radiographic features of aberrant pancreatic rests involving the stomach. Radiology 123(2):291–296.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Park SH, Kim GH, Park DY et al (2011) Endosonographic findings of gastric ectopic pancreas: a single center experience. J Gastroenterol Hepatol 26(9):1441–1446.

    Article  PubMed  Google Scholar 

  26. 26.

    Chou JW, Cheng KS, Ting CF, Feng CL, Lin YT, Huang WH (2014) Endosonographic features of histologically proven gastric ectopic pancreas. Gastroenterol Res Pract 2014:160601.

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Shanbhogue AK, Fasih N, Surabhi VR, Doherty GP, Shanbhogue DKP, Sethi SK (2009) A clinical and radiologic review of uncommon types and causes of pancreatitis. Radiographics 29(4):1003–1026.

    Article  PubMed  Google Scholar 

  28. 28.

    Park JY, Lee ES, Hwang HW, Park HJ, Choi CH (2021) Heterotopic pancreas: the added value of endoscopic ultrasound with Computed Tomography for diagnosis. Med Ultrason 23(1):22–28.

    Article  PubMed  Google Scholar 

  29. 29.

    Attwell A, Sams S, Fukami N (2015) Diagnosis of ectopic pancreas by endoscopic ultrasound with fine-needle aspiration. World J Gastroenterol 21(8):2367–2373.

    Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Wang D, Wei XE, Yan L, Zhang YZ, Li WB (2011) Enhanced CT and CT virtual endoscopy in diagnosis of heterotopic pancreas. World J Gastroenterol 17(33):3850–3855.

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Yang CW, Liu XJ, Wei Y et al (2021) Use of computed tomography for distinguishing heterotopic pancreas from gastrointestinal stromal tumor and leiomyoma. Abdom Radiol (NY) 46(1):168–178.

    CAS  Article  Google Scholar 

  32. 32.

    Li LM, Feng LY, Chen XH, Liang P, Li J, Gao JB (2018) Gastric heterotopic pancreas and stromal tumors smaller than 3 cm in diameter: clinical and computed tomography findings. Cancer Imaging 18(1):26.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Lee NK, Kim S, Jeon TY et al (2010) Complications of congenital and developmental abnormalities of the gastrointestinal tract in adolescents and adults: evaluation with multimodality imaging. Radiographics 30(6):1489–1507.

    Article  PubMed  Google Scholar 

  34. 34.

    Kim SH, Kim SH, Kim MA, Shin CI, Han JK, Choi BI (2015) CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas. Eur Radiol 25(7):1946–1957.

    Article  PubMed  Google Scholar 

  35. 35.

    Okuhata Y, Maebayashi T, Furuhashi S et al (2010) Characteristics of ectopic pancreas in dynamic gadolinium-enhanced MRI. Abdom Imaging 35(1):85–87.

    Article  PubMed  Google Scholar 

  36. 36.

    Silva AC, Charles JC, Kimery BD, Wood JP, Liu PT (2006) MR Cholangiopancreatography in the detection of symptomatic ectopic pancreatitis in the small-bowel mesentery. AJR Am J Roentgenol 187(2):W195–W197.

    Article  PubMed  Google Scholar 

  37. 37.

    Adsay NV, Zamboni G (2004) Paraduodenal pancreatitis: a clinico-pathologically distinct entity unifying “cystic dystrophy of heterotopic pancreas”, “para-duodenal wall cyst”, and “groove pancreatitis.” Semin Diagn Pathol 21(4):247–254.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Raman SP, Salaria SN, Hruban RH, Fishman EK (2013) Groove pancreatitis: spectrum of imaging findings and radiology-pathology correlation. AJR Am J Roentgenol 201(1):W29-39.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Kim DU, Lubner MG, Mellnick VM, Joshi G, Pickhardt PJ (2017) Heterotopic pancreatic rests: imaging features, complications, and unifying concepts. Abdom Radiol (NY) 42(1):216–225.

    Article  Google Scholar 

  40. 40.

    Hur BY, Kim SH, Choi JY et al (2011) Gastroduodenal glomus tumors: differentiation from other subepithelial lesions based on dynamic contrast-enhanced CT findings. AJR Am J Roentgenol 197(6):1351–1359.

    Article  PubMed  Google Scholar 

  41. 41.

    Liu C, Yang F, Zhang W et al (2021) CT differentiation of gastric ectopic pancreas from gastric stromal tumor. BMC Gastroenterol 21(1):52.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Kim JH, Lim JS, Lee YC et al (2008) Endosonographic features of gastric ectopic pancreases distinguishable from mesenchymal tumors. J Gastroenterol Hepatol 23(8 Pt 2):e301–e307.

    Article  PubMed  Google Scholar 

  43. 43.

    Jang KM, Kim SH, Park HJ et al (2013) Ectopic pancreas in upper gastrointestinal tract: MRI findings with emphasis on differentiation from submucosal tumor. Acta Radiol 54(10):1107–1116.

    Article  PubMed  Google Scholar 

  44. 44.

    Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M (2003) Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 23(2):283–304, 456 (quiz 532).

  45. 45.

    Nilsson B, Bümming P, Meis-Kindblom JM et al (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. Cancer 103(4):821–829.

    Article  PubMed  Google Scholar 

  46. 46.

    Nishida T, Goto O, Raut CP, Yahagi N (2016) Diagnostic and treatment strategy for small gastrointestinal stromal tumors. Cancer 122(20):3110–3118.

    Article  PubMed  Google Scholar 

  47. 47.

    Okten RS, Kacar S, Kucukay F, Sasmaz N, Cumhur T (2012) Gastric subepithelial masses: evaluation of multidetector CT (multiplanar reconstruction and virtual gastroscopy) versus endoscopic ultrasonography. Abdom Imaging 37(4):519–530.

    Article  PubMed  Google Scholar 

  48. 48.

    Voltaggio L, Murray R, Lasota J, Miettinen M (2012) Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature. Hum Pathol 43(5):650–659.

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Sarlomo-Rikala M, Miettinen M (1995) Gastric schwannoma—a clinicopathological analysis of six cases. Histopathology 27(4):355–360.

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Levy AD, Quiles AM, Miettinen M, Sobin LH (2005) Gastrointestinal schwannomas: CT features with clinicopathologic correlation. AJR Am J Roentgenol 184(3):797–802.

    Article  PubMed  Google Scholar 

  51. 51.

    Melvin WS, Wilkinson MG (1993) Gastric schwannoma. Clinical and pathologic considerations. Am Surg 59(5):293–296

    CAS  PubMed  Google Scholar 

  52. 52.

    Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438(1):1–12.

    CAS  Article  Google Scholar 

  53. 53.

    Lee MJ, Lim JS, Kwon JE et al (2007) Gastric true leiomyoma: computed tomographic findings and pathological correlation. J Comput Assist Tomogr 31(2):204–208.

    Article  PubMed  Google Scholar 

  54. 54.

    Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128(6):1717–1751.

    Article  PubMed  Google Scholar 

  55. 55.

    Arnold R, Trautmann ME, Creutzfeldt W et al (1996) Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38(3):430–438.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Cives M, Strosberg JR (2018) Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 68(6):471–487.

    Article  PubMed  Google Scholar 

  57. 57.

    Von Der Ohe MR, Camilleri M, Kvols LK, Thomforde GM (1993) Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 329(15):1073–1078.

    Article  PubMed  Google Scholar 

  58. 58.

    Sandor A, Modlin IM (1998) A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol 93(3):422–428.

    CAS  Article  PubMed  Google Scholar 

  59. 59.

    Anthony LB, Strosberg JR, Klimstra DS et al (2010) The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 39(6):767–774.

    Article  PubMed  Google Scholar 

Download references


This research was supported by National Nature Science Foundations of China (Grant Number 82001810) and the 1.3.5 project for disciplines of Excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University (Grant Number 19HXFH054).

Author information




C-WY and FC collected materials. C-WY and X-JL wrote the manuscript. YY, BZ, and BS revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Bo Zhang or Bin Song.

Ethics declarations

Ethics approval and consent to participate

The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This retrospective study was approved by the institutional review board at West China Hospital, Sichuan University (No. 2020-249). Informed consent was obtained from each patient before performing radiological examination.

Consent for publication

All authors and all patients involved are agreed to the publication of this manuscript.

Competing interests

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, CW., Che, F., Liu, XJ. et al. Insight into gastrointestinal heterotopic pancreas: imaging evaluation and differential diagnosis. Insights Imaging 12, 144 (2021).

Download citation


  • Gastrointestinal heterotopic pancreas
  • Computed tomography
  • Imaging features
  • Gastrointestinal subepithelial tumors